Gunagratinib (ICP-192) is a low toxicity and orally activepan-FGFR(fibroblast growth factor receptors) inhibitor that potently and selectively inhibitsFGFRactivities irreversibly by covalent binding. Gunagratinib can be used for the research ofcancer^[1].

Gunagratinib (ICP-192) is a low toxicity and orally active pan-FGFR (fibroblast growth factor receptors) inhibitor that potently and selectively inhibits FGFR activities irreversibly by covalent binding^[1].

423.47

Solid

C₂₂H₂₅N₅O₄

2211082-53-8

Room temperature in continental US; may vary elsewhere.

4°C, sealed storage, away from moisture and light

*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)